The Imbalance Between Oxygen Demand and Supply as a Potential Mechanism in the Pathophysiology of Heart Failure: The Role of Microvascular Growth and Abnormalities

REFERENCES

• Abraham D, Hofbauer R, Schafer R, Blurner R, Pau-lus P, Miksovsky A, Traxler H, Kocher A, Aharine-jad S. (2000). Selective downregulation of VEGF-A (165), VEGF-R (1), and decreased capillary density in patients with dilative but not ischemic cardiomy-opathy. Circ Res 87:644–647.
   PubMed Web of Science ®Google Scholar
• Amann K, Breitbach M, Ritz E, Mall G. (1998). Myocyte/capillary mismatch in the heart of uremic Patients. J Am Soc Nephrol 9:1018–1022.
   PubMedGoogle Scholar
• Arnann K, Munter K, Wessels S, Wagner J, Balajew V, Hergenroder S, Mall G, Ritz E. (2000). Endothe-lin A receptor blockade prevents capillary/myocyte mismatch in the heart of uremic animals. J Am Soc Nephrol 11:1702–1711.
   Google Scholar
• Arnann K, Neirneier KA, Schwarz U, Tornig J, Mat-thias S, Orth SR, Mall G, Ritz E. (1997). Rats with moderate renal failure show capillary deficit in heart but not skeletal muscle. Am J Kidney Dis 30:382–388.
   Google Scholar
• Ando J, Nomura H, Karniya A. (1987). The effect of fluid shear stress on the migration and proliferation of cultured endothelial cells. Microvasc Res 33:62–70.
   PubMed Web of Science ®Google Scholar
• Antonios TF, Kaski JC, Hasan KM, Brown SJ, Singer DR. (2001). Rarefaction of skin capillaries in pa-tients with anginal chest pain and normal coronary arteriograrns. Eur Heart J 22:1144–1148.
   PubMedGoogle Scholar
• Anversa P, Capasso JIM. (1991). Loss of intermedi- ate-sized coronary arteries and capillary prolifera-tion after left ventricular failure in rats. Am J Physiol 260:H1552–H1560.
   Google Scholar
• Anversa P, Capasso JM, Ricci R, Sonnenblick EH, Olivetti G. (1989). Morphometric analysis of coro-nary capillaries during physiologic myocardial growth and induced cardiac hypertrophy: a review. Int J Microcirc Clin Exp 8:353–363.
   Google Scholar
• Anversa P, Ricci R, Olivetti G. (1986). Quantitative structural analysis of the myocardium during physi-ologic growth and induced cardiac hypertrophy: A review. J Am Coll Cardiol 7:1140–1149.
   PubMed Web of Science ®Google Scholar
• Anversa P, Ricci R, Olivetti G. (1987). Effects of exercise on the capillary vasculature of the rat heart. Circulation 75:112–118.
   Google Scholar
• Breisch EA, White FC, Hammond HK, Flynn S, Bloor CM. (1989). Myocardial characteristics of thy-roxine stimulated hypertrophy: A structural and functional study. Basic Res Cardiol 84:345–358.
   Google Scholar
• Brilla CG, Funck RC, Rupp H. (2000). Lisinopril-mediated regression of myocardial fibrosis in pa-tients with hypertensive heart disease. Circulation 102:1388–1393.
   PubMed Web of Science ®Google Scholar
• Bristow MR. (2000). Beta-adrenergic receptor blockade in chronic heart failure. Circulation 101: 558–569.
   PubMed Web of Science ®Google Scholar
• Brush JE Jr, Cannon RO III, Schenke WH, Bonow RO, Leon MB, Maron BJ, Epstein SE. (1988). An-gina due to coronary microvascular disease in hy-pertensive patients without left ventricular hyper-trophy. N Engl J Med 319:1302–1307.
   Google Scholar
• Chen Y, Tony RJ, Baurnbach GL, Tomanek RJ. (1994). Proportional arteriolar growth accompanies cardiac hypertrophy induced by volume overload. Am J Physiol 267:H2132–H2137.
   Google Scholar
• Chen Y, Traverse JH, Du R, Hou M, Bache RJ. (2002). Nitric oxide modulates myocardial oxygen consumption in the failing heart. Circulation 106: 273–279.
   Google Scholar
• Chilian W1VI, Wangler RD, Peters KG, Tomanek RJ, Marcus ML. (1985). Thyroxine-induced left ven-tricular hypertrophy in the rat: Anatomical and physiological evidence for angiogenesis. Circ Res 57: 591–598.
   Google Scholar
• Chua CC, Harndy RC, Chua BH. (1998). Upregula-tion of vascular endothelial growth factor by angio-tensin II in rat heart endothelial cells. Biochim Bio-phys Acta 1401:187–194.
   PubMed Web of Science ®Google Scholar
• Colucci WS. (1997). Molecular and cellular mecha-nisms of myocardial failure. Am J Cardiol 80:15L–25L.
   Google Scholar
• Cooke JP, Losordo DW. (2002). Nitric oxide and angiogenesis. Circulation 105:2133–2135.
   PubMed Web of Science ®Google Scholar
• Davis LE, Hohirner AR, Morton MJ. (1999). Myo-cardial blood flow and coronary reserve in chroni-cally anemic fetal lambs. Am J Physiol 277:R306–R313.
   Google Scholar
• de Boer RA, Henning RH, Tio RA, Pinto YM, Brou- wer RMHJ, Ploeg RJ, Bohm M, van Gilst WH, van Veldhuisen DJ. (2002). Identification of a specific pattern of downregulation in expression of vascular endothelial growth factor (VEGF) in dilated cardio-myopathy. Heart 4:412–414.
   Google Scholar
• de Boer RA, Siebelink HJ, Tio RA, Boomsma F, van Veldhuisen DJ. (2001). Carvedidol increases plasma vascular endothelial growth factor (VEGF) in pa-tients with chronic heart failure. Eur J Heart Fail 3:331–333.
   Google Scholar
• de Jong BM, Cornel JH, Crijns HJ, van Veldhuisen DJ. (2001). Abnormal contractile responses during dobutarnine stress echocardiography in patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail 3:429–436.
   Google Scholar
• Drexler H, Hayoz D, Munzel T, Hornig B, Just H, Brunner HR, Zelis R. (1992). Endothelial function in chronic congestive heart failure. Am J Cardiol 69: 1596–1601.
   PubMed Web of Science ®Google Scholar
• Dvorak HF, Brown LF, Detrnar M, Dvorak AM. (1995). Vascular permeability factor/vascular en-dothelial growth factor, microvascular hyperperme-ability, and angiogenesis. Am J Pathol 146:1029–1039.
   PubMed Web of Science ®Google Scholar
• Emanueli C, Salis MB, Stacca T, Pinna A, Gaspa L, Maddeddu P. (2002). Angiotensin AT(1) receptor signalling modulates reparative angiogenesis in-duced by limb ischaemia. Br J Pharmacol 135:87–92.
   Google Scholar
• Fabre JE, Rivard A, Magner M, Silver M, Isner ym. (1999). Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. Cir-culation 99:3043–3049.
   Google Scholar
• Factor SM, Sonnenblick EH. (1982). Hypothesis: is congestive cardiomyopathy caused by a hyperreac-tive myocardial microcirculation (microvascular spasm) ? Am J Cardiol 50:1149–1152.
   Google Scholar
• Fernandez LA, Twickler J, Mead A. (1985). Neo-vascularization produced by angiotensin II. J Lab Clin Med 105:141–145.
   PubMed Web of Science ®Google Scholar
• Ferrari R, Bachetti T, Agnoletti L, Comini L, Curello S. (1998). Endothelial function and dysfunction in heart failure. Eur Heart J 19(Suppl G):G41–G47.
   Google Scholar
• Figulla HR, Vetterlein F, Glaubitz M, Kreuzer H. (1987). Inhomogenous capillary flow and its pre-vention by veraparnil and hydralazine in the cardio-myopathic Syrian hamster. Circulation 76:208–216.
   Google Scholar
• Folkman J, D'Arnore PA. (1996). Blood vessel for-mation: What is its molecular basis? Cell 87:1153–1155.
   Google Scholar
• Folkman J, Moscona A. (1978). Role of cell shape in growth control. Nature 273:345–349.
   PubMed Web of Science ®Google Scholar
• Folkman J, Shing Y. (1992). Angiogenesis. J Biol Chem 267:10931–10934.
   PubMed Web of Science ®Google Scholar
• Fox KF, Cowie MR, Wood DA, Coats AJ, Gibbs JS, Underwood SR, Turner RM, Poole-Wilson PA, Dav-ies SW, Sutton GC. (2001). Coronary artery disease as the cause of incident heart failure in the popula-tion. Eur Heart J 22:228–236.
   PubMed Web of Science ®Google Scholar
• Fujiyarna S, Matsubara H, Nozawa Y, Maruyarna K, Mori Y, Tsutsumi Y, Masaki H, Uchiyama Y, Koyarna Y, Nose A, Iba O, Tateishi E, Ogata N, Jyo N, Higashiyarna S, Iwasaka T. (2001). Angiotensin AT (1) and AT (2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth fac-tor expression and angiogenesis by modulating hep-arin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circ Res 88: 22–29.
   Google Scholar
• Gavin JIB, Maxwell L, Edgar SG. (1998). Microvas-cular involvement in cardiac pathology. J Mol Cell Cardiol 30:2531–2540.
   PubMed Web of Science ®Google Scholar
• Gerber BL, Rochitte CE, Melin JA, McVeigh ER, Bluemke DA, Wu KC, Becker LC, Lima JA. (2000). Microvascular obstruction and left ventricular re-modeling early after acute myocardial infarction. Circulation 101:2734–2741.
   PubMed Web of Science ®Google Scholar
• Goussev A, Sharov VG, Shirnoyarna H, Tanirnura M, Lesch M, Goldstein S, Sabbah FIN. (1998). Ef-fects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure. Am J Physiol 275:H626–H631.
   Google Scholar
• Gruden G, Thomas S, Burt D, Zhou W, Chusney G, Gnudi L, Viberti G. (1999). Interaction of angioten-sin II and mechanical stretch on vascular endothelial growth factor production by human mesangial cells. J Am Soc Nephrol 10:730–737.
   PubMed Web of Science ®Google Scholar
• Guillemin K, Krasnow MA. (1997). The hypoxic re-sponse: huffing and HIFing. Cell 89:9–12.
   PubMed Web of Science ®Google Scholar
• Haleen SJ, Weishaar RE, Overhiser RW, Bousley RF, Keiser JA, Rapundalo SR, Taylor DG. (1991). Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and sur-vival in the cardiomyopathic hamster: Hemody-narnic, morphological, and biochemical correlates. Circ Res 68:1302–1312.
   Google Scholar
• Hashimoto E, Ogita T, Nakaoka T, Matsuoka R, Takao A, Kira Y. (1994). Rapid induction of vas-cular endothelial growth factor expression by tran-sient ischemia in rat heart. Am J Physiol 267: H1948–H1954.
   Google Scholar
• Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, Mc-Kenna WJ, Fowler MB. (1996). Expression of in-ducible nitric oxide synthase in human heart failure. Circulation 93:1087–1094.
   PubMed Web of Science ®Google Scholar
• Heling A, Zimmermann R, Kostin S, Maeno Y, Hein S, Devaux B, Bauer E, Klovekorn WP, Schlepper M, Schaper W, Schaper J. (2000). Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res 86:846–853.
   PubMed Web of Science ®Google Scholar
• Heron MI, Kolar F, Papousek F, Rakusan K. (1997). Early and late effect of neonatal hypo- and hyper-thyroidism on coronary capillary geometry and long-term heart function in rat. Cardiovasc Res 33: 230–240.
   Google Scholar
• Heymes C, Vanderheyden M, Bronzwaer JGF, Shah AM, Paulus WJ. (1999). Endomyocardial nitric ox-ide synthase and left ventricular preload reserve in dilated car dio my o p athy . Circulation 99 : 3009–3016.
   PubMed Web of Science ®Google Scholar
• Higuchi ML, Fukasawa S, De Brito T, Parzianello LC, Bellotti G, Rarnires JA. (1999). Different micro-circulatory and interstitial matrix patterns in idio-pathic dilated cardiomyopathy and Chagas' disease: A three dimensional confocal microscopy study. Heart 82:279–285.
   PubMed Web of Science ®Google Scholar
• Hochman JS, Choo H. (1987). Limitation of myo-cardial infarct expansion by reperfusion indepen-dent of myocardial salvage. Circulation 75:299–306.
   PubMed Web of Science ®Google Scholar
• Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wie-gand SJ. (1999). Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994–1998.
   PubMed Web of Science ®Google Scholar
• Hudlická O, Brown MD, Walter H, Weiss JB, Bate A. (1995). Factors involved in capillary growth in the heart. Mol Cell Biochem 147:57–68.
   Google Scholar
• Hudlická O, West D, Kumar S, el Khelly F, Wright AJ. (1989). Can growth of capillaries in the heart and skeletal muscle be explained by the presence of an angiogenic factor? Br J Exp Pathol 70:237–246.
   Google Scholar
• Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, Symes JF. (1996). Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348:370–374.
   PubMed Web of Science ®Google Scholar
• Jackson JR, Minton JA, Ho ML, Wei N, Winkler JD. (1997). Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin-1beta. J Rheumatol 24:1253–1259.
   PubMed Web of Science ®Google Scholar
• Kakinurna Y, Miyauchi T, Yuki K, Murakoshi N, Goto K, Yamaguchi I. (2001). Novel molecular mechanism of increased myocardial endothelin-1 expression in the failing heart involving the tran-scriptional factor hypoxia-inducible factor-1alpha induced for impaired myocardial energy metabo-lism. Circulation 103:2387–2394.
   Google Scholar
• Kalkman EA, van Haren P, Saxena PR, Schoemaker RG. (1999). Early captopril prevents myocardial in-farction-induced hypertrophy but not angiogenesis. Eur J Pharmacol 369:339–348.
   Google Scholar
• Kawano H, Do YS, Kawano Y, Starnes V, Barr M, Law RE, Hsueh WA. (2000). Angiotensin II has multiple profibrotic effects in human cardiac fibro-blasts. Circulation 101:1130–1137.
   PubMed Web of Science ®Google Scholar
• Kayar SR, Weiss HR. (1992). Diffusion distances, total capillary length and mitochondrial volume in pressure-overload myocardial hypertrophy. J Mol Cell Cardiol 24:1155–1166.
   PubMed Web of Science ®Google Scholar
• Kelly RA, Balligand J-L, Smith TW. (1996). Nitric oxide and cardiac function. Circ Res 79:363–380.
   PubMed Web of Science ®Google Scholar
• Kumamoto H, Okamoto H, Watanabe M, Onozuka H, Yoneya K, Nakagawa I, Chiba S, Watanabe S, Mikarni T, Abe K, Kitabatake A. (1999). Beneficial effect of myocardial angiogenesis on cardiac remod-eling process by arnlodipine and MCI-154. Am J Physiol 276:H1117–H1123.
   Google Scholar
• Kuo NT, Benhayon D, Przybylski RJ, Martin RJ, LaManna JC. (1999). Prolonged hypoxia increases vascular endothelial growth factor mRNA and pro-tein in adult mouse brain. J Appl Physiol 86:260–264.
   Google Scholar
• Lansman JIB, Hallam TJ, Rink TJ. (1987). Single stretch-activated ion channels in vascular endothe-lial cells as mechanotransducers? Nature 325:811–813.
   Google Scholar
• Larouche I, Schiffrin EL. (1999). Cardiac microvas-culature in DOCA-salt hypertensive rats: effect of endothelin ET (A) receptor antagonism. Hyperten-sion 34:795–801.
   PubMed Web of Science ®Google Scholar
• Laughlin MH, McAllister RM. (1992). Exercise training-induced coronary vascular adaptation. J Appl Physiol 73:2209–2225.
   PubMedGoogle Scholar
• Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA. (2000). Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342:626–633.
   PubMed Web of Science ®Google Scholar
• Levy AP. (1999). A cellular paradigm for the failure to increase vascular endothelial growth factor in chronically hypoxic states. Coron Artery Dis 10: 427–430.
   Google Scholar
• Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA. (2001). Microcirculation in hypertension: a new target for treatment? Circulation 104:735–740.
   Google Scholar
• Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M. (1996). VEGF, flk-1, and flt-1 ex-pression in a rat myocardial infarction model of an-giogenesis. Am J Physiol 270:H1803–H1811.
   Google Scholar
• Li J, Hampton T, Morgan JP, Simons M. (1997). Stretch-induced VEGF expression in the heart. J Clin Invest 100:18–24.
   PubMed Web of Science ®Google Scholar
• Liu PP, Mak S, Stewart DJ. (1999). Potential role of the microvasculature in progression of heart failure. Am J Cardiol 84 (Suppl 4A):23L–26L.
   Google Scholar
• Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, Ashare AB, Lathi K, Isner ym. (1998). Gene therapy for myocardial angiogen-esis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myo-cardial ischemia. Circulation 98:2800–2804.
   PubMed Web of Science ®Google Scholar
• Martin C, Yu AY, Jiang BH, Davis L, Kimberly D, Hohirner AR, Semenza GL. (1998). Cardiac hyper-trophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocar-dial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. Am J Obstet Gyne-col 178:527–534.
   PubMed Web of Science ®Google Scholar
• Masuda S, Nagao M, Sasaki R. (1999). Erythropoi-etic, neurotrophic, and angiogenic functions of erythropoietin and regulation of erythropoietin pro-duction. Int J Hematol 70:1–6.
   Google Scholar
• Matsunaga T, Weihrauch DW, Moniz MC, Tesmer J, Warltier DC, Chilian WM. (2002). Angiostatin in-hibits coronary angiogenesis during impaired pro-duction of nitric oxide. Circulation 105:2185–2191.
   PubMed Web of Science ®Google Scholar
• Maxwell PH, Dachs GU, Gleadle ym, Nicholls LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW, Ratcliffe PJ. (1997). Hypoxia-inducible factor-1 modulates gene expression in solid tumors and in-fluences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 94:8104–8109.
   PubMed Web of Science ®Google Scholar
• McAinsh AM, Geyer M, Fandrey J, Ruegg JC, Wies-ner RJ. (1998). Expression of vascular endothelial growth factor during the development of cardiac hy-pertrophy in spontaneously hypertensive rats. Mol Cell Biochem 187:141–146.
   Google Scholar
• Michael LH, Ballantyne CM, Zachariah JP, Gould KE, Pocius JS, Taffet GE, Hartley CJ, Pharn TT, Daniel SL, Funk E, Entrnan ML. (1999). Myocar-dial infarction and remodeling in mice: Effect of reperfusion. Am J Physiol 277:H660–H668.
   Google Scholar
• Mosseri M, Schaper J, Admon D, Hasin Y, Gotsman MS, Sapoznikov D, Pickering JG, Yarom R. (1991). Coronary capillaries in patients with congestive car-diomyopathy or angina pectoris with patent main coronary arteries: Ultrastructural morphometry of endomyocardial biopsy samples. Circulation 84: 203–210.
   Google Scholar
• Moulton KS, Heller E, Konerding MA, Flynn E, Pa-linski W, Folkman J. (1999). Angiogenesis inhibi-tors endostatin or TNP-470 reduce intirnal neovas-cularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99:1726–1732.
   PubMed Web of Science ®Google Scholar
• Munzenrnaier DH, Greene AS. (1996). Opposing ac-tions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension 27:760–765.
   Google Scholar
• Nakamura R, Egashira K, Arirnura K, Machida Y, Ide T, Tsutsui H, Shimokawa H, Takeshita A. (2001). Increased inactivation of nitric oxide is in-volved in impaired coronary flow reserve in heart failure. Am J Physiol 281:H2619–H2625.
   Google Scholar
• Nelissen-Vrancken HJ, Kuizinga MC, Daemen MJ, Smits JF. (1998). Early captopril treatment inhibits DNA synthesis in endothelial cells and normaliza-tion of maximal coronary flow in infarcted rat hearts. Cardiovasc Res 40:156–164.
   Google Scholar
• Nikolaidis LA, Doverspike A, Huerbin R, Hentosz T, Shannon RP. (2002). Angiotensin-converting en-zyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism. Circulation 105: 2785–2790.
   PubMed Web of Science ®Google Scholar
• Nikolaidis LA, Hentosz T, Doverspike A, Huerbin R, Stolarski C, Shen YT, Shannon RP. (2001). Mecha-nisms whereby rapid RV pacing causes LV dysfunc- tion: Perfusion-contraction matching and NO. Am J Physiol 281:H2270–H2281.
   Google Scholar
• Nomura M, Yarnagishi S, Harada S, Hayashi Y, Ya-mashirna T, Yamashita J, Yamamoto H. (1995). Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and peri-cytes. J Biol Chem 270:28316–28324.
   PubMed Web of Science ®Google Scholar
• Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, Watt GC. (1997). Impaired mi-crovascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 99:1873–1879.
   PubMed Web of Science ®Google Scholar
• Olfert LVI, Breen EC, Mathieu-Costello O, Wagner PD. (2001). Chronic hypoxia attenuates resting and exercise-induced VEGF, flt-1, and flk-1 mRNA lev-els in skeletal muscle. J Appl Physiol 90:1532–1538.
   Google Scholar
• Olivetti G, Lagrasta C, Quaini F, Ricci R, Moccia G, Capasso JM, Anversa P. (1989). Capillary growth in anemia-induced ventricular wall remodeling in the rat heart. Circ Res 65:1182–1192.
   Google Scholar
• Otani A, Takagi H, Suzurna K, Honda Y. (1998). Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. Circ Res 82:619–628.
   PubMed Web of Science ®Google Scholar
• Packer M. (1992). The neurohormonal hypothesis: A theory to explain the mechanism of disease pro-gression in heart failure. J Am Coll Cardiol 20:248–254.
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC. (1992). Effect of captopril on mor-tality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327:669–677.
   PubMed Web of Science ®Google Scholar
• Pinto YM, Pinto-Sietsma SJ, Philipp T, Engler S, Kobetarnehl P, Hocher B, Marquardt H, Sethrnann S, Lauster R, Merker HJ, Paul M. (2000). Reduction in left ventricular messenger RNA for transforming growth factor-131 attenuates left ventricular fibrosis and improves survival without lowering blood pres-sure in the hypertensive TGR (mRen2)27 Rat. Hy-pertension 36:747–754.
   Google Scholar
• Pinto YM, van Gilst WH, Kingma JH, Schunkert H. (1995). Deletion-type allele of the angiotensin-converting enzyme gene is associated with progres-sive ventricular dilation after anterior myocardial infarction: Captopril and Thrombolysis Study Inves-tigators. J Am Coll Cardiol 25:1622–1626.
   PubMed Web of Science ®Google Scholar
• Pupilli C, Lasagni L, Romagnani P, Bellini F, Man-nelli M, Misciglia N, Mavilia C, Vellei U, Villari D, Serio M. (1999). Angiotensin II stimulates the syn-thesis and secretion of vascular permeability factor/ vascular endothelial growth factor in human mes-angial cells. J Am Soc Nephrol 10:245–255.
   Google Scholar
• Rakusan K, Cicutti N, Kolar F. (2001). Effect of anemia on cardiac function, microvascular struc-ture, and capillary hematocrit in rat hearts. Am J Physiol Heart Circ Physiol 280:H1407–H1414.
   Google Scholar
• Rakusan K, Flanagan MF, Geva T, Southern J, van Praagh R. (1992). Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertro-phy. Circulation 86:38–46.
   PubMed Web of Science ®Google Scholar
• Rarnaciotti C, Sharkey A, McClellan G, Winegrad S. (1992). Endothelial cells regulate cardiac contrac-tility. Proc Natl Acad Sci USA 89:4033–4036.
   Google Scholar
• Richard V, Murry CE, Reimer KA. (1995). Healing of myocardial infarcts in dogs. Effects of late reper-fusion. Circulation 92:1891–1901.
   Google Scholar
• Risau W. (1997). Mechanisms of angiogenesis. Na-ture 386:671–674.
   PubMed Web of Science ®Google Scholar
• Rongish BJ, Torry RJ, Tomanek RJ. (1995). Coro-nary neovascularization of embryonic rat hearts cul-tured in oculo is independent of thyroid hormones. Am J Physiol 268:H811–H816.
   Google Scholar
• Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereux RB, Post MR, Hackett NR, Foster T, Grasso TM, Lesser ML, Isom OW, Crystal RG. (1999). Angiogenesis gene therapy: phase I assessment of direct intrarnyo-cardial administration of an adenovirus vector ex-pressing VEGF121 cDNA to individuals with clini-cally significant severe coronary artery disease. Cir-culation 100:468–474.
   PubMed Web of Science ®Google Scholar
• Rossig L, Haendeler J, Mallat Z, Hugel B, Freyssinet JM, Tedgui A, Dimmeler S, Zeiher AM. (2000). Congestive heart failure induces endothelial cell ap-optosis: Protective role of carvedilol. J Am Coll Car-diol 36:2081–2089.
   PubMed Web of Science ®Google Scholar
• Ruffolo RR Jr, Feuerstein GZ. (1998). Carvedilol: Preclinical profile and mechanisms of action in pre-venting the progression of congestive heart failure. Eur Heart J 19(Suppl B):B19–B24.
   Google Scholar
• Sabri A, Samuel JL, Marotte F, Poitevin P, Rappa-port L, Levy BI. (1998). Microvasculature in angio-tensin II-dependent cardiac hypertrophy in the rat. Hypertension 32:371–375.
   PubMed Web of Science ®Google Scholar
• Saito T, Maehara K, Tamagawa K, Oikawa Y, Niit-surna T, Saitoh S, Maruyarna Y. (2002). Alterations of endothelium-dependent and -independent regu-lation of coronary blood flow during heart failure. Am J Physiol 282:H80–H86.
   Google Scholar
• Schaper W, Buschrnann I. (1999). Arteriogenesis, the good and bad of it. Eur Heart J20:1297–1299.
   Google Scholar
• Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, Drexler H. (1994). Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on car-diac remodeling after myocardial infarction in the rat. Circulation 89:2273–2282.
   PubMed Web of Science ®Google Scholar
• Schwartzkopff B, Mundhenke M, Strauer BE. (1995). Remodelling of intrarnyocardial arterioles and extracellular matrix in patients with arterial hy-pertension and impaired coronary reserve. Eur Heart J 16(Suppl I):82–86.
   Google Scholar
• Sehl PD, Tai JT, Hillan KJ, Brown LA, Goddard A, Yang R, Jin H, Lowe DG. (2000). Application of cDNA microarrays in determining molecular pheno-type in cardiac growth, development, and response to injury. Circulation 101:1990–1999.
   PubMedGoogle Scholar
• Semenza GL, Agani F, Iyer N, Jiang BH, Leung S, Wiener C, Yu A. (1998). Hypoxia-inducible factor 1: From molecular biology to cardiopulmonary physiology. Chest 114:40S–45S.
   Google Scholar
• Shirnoni S, Frangogiarmis NG, Aggeli CJ, Shan K, Quinones MA, Espada R, Letsou GV, Lawrie GM, Winters WL, Reardon MJ, Zoghbi WA. (2002). Mi-crovascular structural correlates of myocardial con-trast echocardiography in patients with coronary artery disease and left ventricular dysfunction: Im-plications for the assessment of myocardial hiberna-tion. Circulation 106:950–956.
   Google Scholar
• Silvestre JS, Bergaya S, Tarnarat R, Duriez M, Bou-langer CM, Levy BI. (2001). Proangiogenic effect of angiotensin-converting enzyme inhibition is medi-ated by the bradykinin B (2) receptor pathway. Circ Res 89:678–683.
   PubMed Web of Science ®Google Scholar
• Sladek T, Sladkova J, Kolar F, Papousek F, Cicutti N, Korecky B, Rakusan K. (1996). The effect of AT1 receptor antagonist on chronic cardiac response to coronary artery ligation in rats. Cardiovasc Res 31: 568–576.
   PubMed Web of Science ®Google Scholar
• Solomon A, Gersh B. (1998). The open-artery hy-pothesis. Annu Rev Med 49:63–76.
   Google Scholar
• Sonnenblick EH, Fein F, Capasso ym, Factor SM. (1985). Microvascular spasm as a cause of cardio-myopathies and the calcium-blocking agent vera-parnil as potential primary therapy. Am J Cardiol 55:179B–184B.
   Google Scholar
• Spinale FG, Grine RC, Tempel GE, Crawford FA, Zile MR. (1992). Alterations in the myocardial cap-illary vasculature accompany tachycardia-induced cardiomyopathy. Basic Res Cardiol 87:65–79.
   Google Scholar
• Spinale FG, Tanaka R, Crawford FA, Zile MR. (1992). Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy. Circulation 85:717–729.
   Web of Science ®Google Scholar
• Spinale FG, Zellner JL, Tomita M, Tempel GE, Crawford FA, Zile MR. (1991). Tachycardia-induced cardiomyopathy: Effects on blood flow and capillary structure. Am J Physiol 261:H140–H148.
   Google Scholar
• Stanton LW, Garrard LJ, Darnrn D, Garrick BL, Lam A, Kapoun AM, Zheng Q, Protter AA, Schreiner GF, White RT. (2000). Altered patterns of gene expression in response to myocardial infarc-tion. Circ Res 86:939–945.
   PubMed Web of Science ®Google Scholar
• Strauer BE, Schwartzkopff B. (1997). Left ventricu-lar hypertrophy and coronary microcirculation in hypertensive heart disease. Blood Press Suppl 2:6–12.
   Google Scholar
• Strauer BE, Schwartzkopff B, Kelm M. (1998). As-sessing the coronary circulation in hypertension. J Hypertens 16:1221–1233.
   PubMed Web of Science ®Google Scholar
• Sun D, Huang A, Zhao G, Bernstein R, Forfia P, Xu X, Koller A, Kaley G, Hintze TH. (2000). Reduced NO-dependent arteriolar dilation during the devel-opment of cardiomyopathy. Am J Physiol 278: H461–H468.
   Google Scholar
• Symes JF, Losordo DW, Vale PR, Lathi KG, Esakof DD, Mayskiy M, Isner ym. (1999). Gene therapy with vascular endothelial growth factor for inoper-able coronary artery disease. Ann Thorac Surg 68: 830–836.
   PubMed Web of Science ®Google Scholar
• Tasgal J, Williams EM. (1981). The effect of pro-longed propranolol administration on myocardial transmural capillary density in young rabbits. J Physiol 315:353–367.
   Google Scholar
• Tomanek RJ, Connell PM, Butters CA, Tony RJ. (1995). Compensated coronary microvascular growth in senescent rats with thyroxine-induced cardiac hypertrophy. Am J Physiol 268:H419–H425.
   Google Scholar
• Tomanek RJ, Doty MK, Sandra A. (1998). Early coronary angiogenesis in response to thyroxine: growth characteristics and upregulation of basic fi-broblast growth factor. Circ Res 82:587–593.
   PubMedGoogle Scholar
• Tomanek RJ, Schalk KA, Marcus ML, Harrison DG. (1989). Coronary angiogenesis during long-term hypertension and left ventricular hypertrophy in dogs. Circ Res 65:352–359.
   Google Scholar
• Tomita Y, Kusarna Y, Seino Y, Munakata K, Kishida H, Hayakawa H. (1997). Increased accumulation of acidic fibroblast growth factor in left ventricular myocytes of patients with idiopathic cardiomyopa-thy. Am Heart J 134:779–786.
   Google Scholar
• Tornig J, Arnann K, Ritz E, Nichols C, Zeier M, Mall G. (1996). Arteriolar wall thickening, capillary rare-faction and interstitial fibrosis in the heart of rats with renal failure:the effects of rarnipril, nifedipine and moxonidine. J Am Soc Nephrol 7:667–675.
   PubMed Web of Science ®Google Scholar
• Unger T, Mattfeldt T, Larnberty V, Bock P, Mall G, Linz W, Scholkens BA, Gohlke P. (1992). Effect of early onset angiotensin converting enzyme inhibi-tion on myocardial capillaries. Hypertension 20: 478–482.
   PubMed Web of Science ®Google Scholar
• Unverferth DV, Magorien RD, Lewis RP, Leier CV. (1983). The role of subendocardial ischemia in per-petuating myocardial failure in patients with non-ischemic congestive cardiomyopathy. Am Heart J 105:176–179.
   Google Scholar
• van den Heuvel AFM, Box JJ, Blanksma PK, Vaal-burg W1VI, Crijns HJGM, van Veldhuisen DJ. (2002). Abnormalities in myocardial contractility, metabo-lism and perfusion reserve in non-stenotic coronary segments in heart failure patients. Cardiovasc Res 55:97–103.
   Google Scholar
• van den Heuvel AFM, Blanksma PK, Siebelink HJ, van Wijk LM, Boomsma F, Vaalburg W1VI, Crijns HJGM, van Veldhuisen DJ. (2001). Impairment of myocardial blood flow reserve in patients with asymptomatic left ventricular dysfunction: Effects of ACE-inhibition with perindopril. Jut J Card Im-aging 17:353–359.
   Google Scholar
• van den Heuvel AFM, van Veldhuisen DJ, van der Wall EE, Blanksma PK, Siebelink HM, Vaalburg WM, van Gilst WH, Crijns HJGM. (2000). Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 35:19–28.
   Google Scholar
• van Veldhuisen DJ, van den Heuvel AFM, Blanksma PK, Crijns HJGM. (1998). Ischemia and left ven-tricular dysfunction: a reciprocal relation? J Cardio-vasc Pharmacol 32:S46–S51.
   Google Scholar
• Vasir B, Aiello LP, Yoon KH, Quickel RR, Bonner-Weir S, Weir GC. (1998). Hypoxia induces vascular endothelial growth factor gene and protein expres-sion in cultured rat islet cells. Diabetes 47:1894–1903.
   PubMed Web of Science ®Google Scholar
• Waltenberger J, Mayr U, Pentz S, Hombach V. (1996). Functional upregulation of the vascular en-dothelial growth factor receptor KDR by hypoxia. Circulation 94:1647–1654.
   PubMed Web of Science ®Google Scholar
• Wang J, Seyedi N, Xu XB, Wolin MS, Hintze TH. (1994). Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure. Am J Physiol 266:H670–H680.
   Google Scholar
• Watanabe Y, Kusuoka H, Fukuchi K, Fujiwara T, Nishimura T. (1997). Contribution of hypoxia to the development of cardiomyopathy in hamsters. Car-diovasc Res 35:217–222.
   PubMedGoogle Scholar
• Williams EM, Tasgal J, Raine AE. (1977). Morpho-metric changes in rabbit ventricular myocardium produced by long-term beta-adrenoceptor blockade. Lancet 2:850–852.
   Google Scholar
• Wright AJ, Hudlická O. (1981). Capillary growth and changes in heart performance induced by chronic bradycardial pacing in the rabbit. Circ Res 49:469–478.
   Google Scholar
• Zhai Y, Ni J, Jiang GW, Lu J, Xing L, Lincoln C, Carter KC, Janat F, Kozak D, Xu S, Rojas L, Ag-garwal BB, Ruben S, Li LY, Gentz R, Yu GL. (1999). VEGI, a novel cytokine of the tumor necro-sis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASER J 13:181–189.
   PubMed Web of Science ®Google Scholar
• Zheng W, Brown MD, Brock TA, Bjercke RJ, To-manek RJ. (1999). Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor. Circ Res 85:192–198.
   Google Scholar
• Zheng W, Seftor EA, Meininger CJ, Hendrix MJ, Tomanek RJ. (2001). Mechanisms of coronary an-giogenesis in response to stretch: Role of VEGF and TGF-beta. Am J Physiol 280:H909–H917.
   Google Scholar
• Zimmermann R, Kastens J, Linz W, Wiemer G, Scholkens BA, Schaper J. (1999). Effect of long-term ACE inhibition on myocardial tissue in hyper-tensive stroke-prone rats. J Mol Cell Cardiol 31: 1447–1456.
   Google Scholar